These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31339674)

  • 1. Health Care Autonomy of Women Living with HIV.
    Redfield RR; Modi S; Moore CA; Delaney A; Honein MA; Tomlinson HL
    N Engl J Med; 2019 Aug; 381(9):798-800. PubMed ID: 31339674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.
    Zash R; Holmes L; Diseko M; Jacobson DL; Brummel S; Mayondi G; Isaacson A; Davey S; Mabuta J; Mmalane M; Gaolathe T; Essex M; Lockman S; Makhema J; Shapiro RL
    N Engl J Med; 2019 Aug; 381(9):827-840. PubMed ID: 31329379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limiting cardiovascular events associated with HIV and antiretroviral therapy.
    Brenner BG; Baril JG
    AIDS; 2017 Nov; 31(18):2551-2553. PubMed ID: 29120901
    [No Abstract]   [Full Text] [Related]  

  • 4. Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.
    Zash R; Makhema J; Shapiro RL
    N Engl J Med; 2018 Sep; 379(10):979-981. PubMed ID: 30037297
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV Drug May Increase Risk of Neural Tube Birth Defects.
    Aschenbrenner DS
    Am J Nurs; 2019 Jan; 119(1):27. PubMed ID: 30589699
    [No Abstract]   [Full Text] [Related]  

  • 6. Dolutegravir Use at Conception - Additional Surveillance Data from Botswana.
    Raesima MM; Ogbuabo CM; Thomas V; Forhan SE; Gokatweng G; Dintwa E; Petlo C; Motswere-Chirwa C; Rabold EM; Tinker SC; Odunsi S; Malima S; Mmunyane O; Modise T; Kefitlhile K; Dare K; Letebele M; Roland ME; Moore CA; Modi S; Williamson DM
    N Engl J Med; 2019 Aug; 381(9):885-887. PubMed ID: 31329378
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing the risk of dolutegravir for women of childbearing potential.
    Schomaker M; Davies MA; Cornell M; Ford N
    Lancet Glob Health; 2018 Sep; 6(9):e958-e959. PubMed ID: 30049617
    [No Abstract]   [Full Text] [Related]  

  • 8. Dolutegravir becomes first choice for HIV.
    Rahimi S
    Lancet Infect Dis; 2019 Sep; 19(9):937-938. PubMed ID: 31478520
    [No Abstract]   [Full Text] [Related]  

  • 9. Dolutegravir for pregnant women living with HIV.
    Zipursky J; Loutfy M
    CMAJ; 2020 Mar; 192(9):E217-E218. PubMed ID: 32122978
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.
    Pinnetti C; Tintoni M; Ammassari A; Tamburrini E; Bernardi S; Liuzzi G; Scambia G; Perno CF; Floridia M; Antinori A; Cavaliere AF
    AIDS; 2015 Nov; 29(18):2534-7. PubMed ID: 26372490
    [No Abstract]   [Full Text] [Related]  

  • 11. Protecting Mothers and Babies - A Delicate Balancing Act.
    Rasmussen SA; Barfield W; Honein MA
    N Engl J Med; 2018 Sep; 379(10):907-909. PubMed ID: 30037313
    [No Abstract]   [Full Text] [Related]  

  • 12. Periconception dolutegravir use in women living with HIV and missed opportunities in maternal and child health.
    Myer L
    Lancet Child Adolesc Health; 2019 Oct; 3(10):669-671. PubMed ID: 31375312
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.
    Mofenson LM; Pozniak AL; Wambui J; Raizes E; Ciaranello A; Clayden P; Ehrenkranz P; Fakoya A; Hill A; Khoo S; Mahaka I; Modi S; Moore C; Phillips A; Siberry G; Sikwese K; Thorne C; Watts HD; Doherty M; Ford NP
    J Int AIDS Soc; 2019 Jul; 22(7):e25352. PubMed ID: 31298496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes to dolutegravir policy in several African countries.
    Nakkazi E
    Lancet; 2018 Jul; 392(10143):199. PubMed ID: 30043745
    [No Abstract]   [Full Text] [Related]  

  • 15. Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice.
    de Boer MG; van den Berk GE; van Holten N; Oryszcyn JE; Dorama W; Moha DA; Brinkman K
    AIDS; 2016 Nov; 30(18):2831-2834. PubMed ID: 27824625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
    Cahn P; Madero JS; Arribas JR; Antinori A; Ortiz R; Clarke AE; Hung CC; Rockstroh JK; Girard PM; Sievers J; Man C; Currie A; Underwood M; Tenorio AR; Pappa K; Wynne B; Fettiplace A; Gartland M; Aboud M; Smith K;
    Lancet; 2019 Jan; 393(10167):143-155. PubMed ID: 30420123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
    Walmsley SL; Antela A; Clumeck N; Duiculescu D; Eberhard A; Gutiérrez F; Hocqueloux L; Maggiolo F; Sandkovsky U; Granier C; Pappa K; Wynne B; Min S; Nichols G;
    N Engl J Med; 2013 Nov; 369(19):1807-18. PubMed ID: 24195548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging does not impact drug--drug interaction magnitudes with antiretrovirals.
    Stader F; Decosterd L; Stoeckle M; Cavassini M; Battegay M; Saldanha SA; Marzolini C; Courlet P;
    AIDS; 2020 May; 34(6):949-952. PubMed ID: 32028327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.
    Vassallo M; De Monte A; Durant J; Dunais B; Cottalorda J
    AIDS; 2016 Sep; 30(14):2257-8. PubMed ID: 27574797
    [No Abstract]   [Full Text] [Related]  

  • 20. HAART improves quality of life: should we care about the quality of spermatozoa?
    Vernazza P
    AIDS; 2008 Mar; 22(5):647-8. PubMed ID: 18317007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.